BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 9681568)

  • 1. Effects of lowest-dose vs. highest-dose pitavastatin on coronary neointimal hyperplasia at 12-month follow-up in type 2 diabetic patients with non-ST elevation acute coronary syndrome: an optical coherence tomography analysis.
    Lim JW; Jeong HS; Hong SJ; Kim HJ; Kim YC; Kang BG; Jeon SM; Cho JY; Lee SH; Joo HJ; Park JH; Yu CW
    Heart Vessels; 2019 Jan; 34(1):62-73. PubMed ID: 30047013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pitavastatin on vascular reactivity in hypercholesterolemic rabbits.
    Almeida EA; Ozaki MR
    Arq Bras Cardiol; 2014 Jul; 103(1):4-12. PubMed ID: 25014056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitavastatin: evidence for its place in treatment of hypercholesterolemia.
    Alagona P
    Core Evid; 2010; 5():91-105. PubMed ID: 21468365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerosis induced by chronic inhibition of the synthesis of nitric oxide in moderately hypercholesterolaemic rabbits is suppressed by pitavastatin.
    Kitahara M; Kanaki T; Ishii I; Saito Y
    Br J Pharmacol; 2010 Apr; 159(7):1418-28. PubMed ID: 20233214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reversal of the inhibition on lipids synthesis by L-659,699 in arterial smooth muscle cells cultures.
    Carazo A; Alejandre MJ; Louktibi A; Linares A
    Mol Cell Biochem; 2001 May; 221(1-2):25-31. PubMed ID: 11506182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK-104, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces osteopontin expression by rat aortic smooth muscle cells.
    Takemoto M; Kitahara M; Yokote K; Asaumi S; Take A; Saito Y; Mori S
    Br J Pharmacol; 2001 May; 133(1):83-8. PubMed ID: 11325797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase.
    Park HJ; Galper JB
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11525-30. PubMed ID: 10500210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestradiol inhibition of vascular myointimal proliferation following immune, chemical and mechanical injury.
    Foegh ML; Zhao Y; Farhat M; Ramwell PW
    Ciba Found Symp; 1995; 191():139-45; discussion 145-9. PubMed ID: 8582194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK-104, a newly developed HMG-CoA reductase inhibitor, suppresses neointimal thickening by inhibiting smooth muscle cell growth and fibronectin production in balloon-injured rabbit carotid artery.
    Kitahara M; Kanaki T; Toyoda K; Miyakoshi C; Tanaka S; Tamaki T; Saito Y
    Jpn J Pharmacol; 1998 Jun; 77(2):117-28. PubMed ID: 9681568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvastatin suppresses intimal thickening of rabbit carotid artery after balloon catheter injury probably through the inhibition of vascular smooth muscle cell proliferation and migration.
    Komukai M; Wajima YS; Tashiro J; Shinomiya M; Saito Y; Morisaki N
    Scand J Clin Lab Invest; 1999 May; 59(3):159-66. PubMed ID: 10400160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.
    Igarashi M; Takeda Y; Mori S; Ishibashi N; Komatsu E; Takahashi K; Fuse T; Yamamura M; Kubo K; Sugiyama Y; Saito Y
    Br J Pharmacol; 1997 Mar; 120(6):1172-8. PubMed ID: 9134232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nifedipine suppresses neointimal thickening by its inhibitory effect on vascular smooth muscle cell growth via a MEK-ERK pathway coupling with Pyk2.
    Hirata A; Igarashi M; Yamaguchi H; Suwabe A; Daimon M; Kato T; Tominaga M
    Br J Pharmacol; 2000 Dec; 131(8):1521-30. PubMed ID: 11139427
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.